152 related articles for article (PubMed ID: 19854496)
21. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
22. TO901317, a potent LXR agonist, is an inverse agonist of CAR.
Kanno Y; Tanuma N; Takahashi A; Inouye Y
J Toxicol Sci; 2013; 38(3):309-15. PubMed ID: 23665929
[TBL] [Abstract][Full Text] [Related]
23. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
24. Regulation of LPCAT3 by LXR.
Demeure O; Lecerf F; Duby C; Desert C; Ducheix S; Guillou H; Lagarrigue S
Gene; 2011 Jan; 470(1-2):7-11. PubMed ID: 20837115
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
[TBL] [Abstract][Full Text] [Related]
26. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.
Jiang Z; Sang H; Fu X; Liang Y; Li L
Biotechnol Appl Biochem; 2015; 62(6):840-7. PubMed ID: 25496323
[TBL] [Abstract][Full Text] [Related]
27. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
[TBL] [Abstract][Full Text] [Related]
28. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors.
Pavan L; Hermouet A; Tsatsaris V; Thérond P; Sawamura T; Evain-Brion D; Fournier T
Endocrinology; 2004 Oct; 145(10):4583-91. PubMed ID: 15242983
[TBL] [Abstract][Full Text] [Related]
29. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.
Li N; Wang X; Xu Y; Lin Y; Zhu N; Liu P; Lu D; Si S
Mol Pharmacol; 2017 Apr; 91(4):264-276. PubMed ID: 28087808
[TBL] [Abstract][Full Text] [Related]
32. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
33. Andrographolide Inhibits Oxidized LDL-Induced Cholesterol Accumulation and Foam Cell Formation in Macrophages.
Lin HC; Lii CK; Chen HC; Lin AH; Yang YC; Chen HW
Am J Chin Med; 2018; 46(1):87-106. PubMed ID: 29298513
[TBL] [Abstract][Full Text] [Related]
34. A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia.
Zhang B; Noda K; Matsunaga A; Kumagai K; Saku K
J Atheroscler Thromb; 2005; 12(1):41-7. PubMed ID: 15725695
[TBL] [Abstract][Full Text] [Related]
35. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells.
Dje N'Guessan P; Riediger F; Vardarova K; Scharf S; Eitel J; Opitz B; Slevogt H; Weichert W; Hocke AC; Schmeck B; Suttorp N; Hippenstiel S
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):380-6. PubMed ID: 19122173
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
37. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
38. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
Sato K; Kamada T
Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
[TBL] [Abstract][Full Text] [Related]
39. The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia?
Plösch T; Gellhaus A; van Straten EM; Wolf N; Huijkman NC; Schmidt M; Dunk CE; Kuipers F; Winterhager E
Placenta; 2010 Oct; 31(10):910-8. PubMed ID: 20709391
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.
Zhang X; Samadi AK; Roby KF; Timmermann B; Cohen MS
Gynecol Oncol; 2012 Mar; 124(3):606-12. PubMed ID: 22188785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
